These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 29553861

  • 1. Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.
    Li H, Gui H, Yuan G, Zheng X, Gao C, Yuan H.
    Scand J Clin Lab Invest; 2018 Jul; 78(4):269-274. PubMed ID: 29553861
    [Abstract] [Full Text] [Related]

  • 2. Circulating mircoRNA-21 as a predictor for vascular restenosis after interventional therapy in patients with lower extremity arterial occlusive disease.
    Zhang B, Yao Y, Sun QF, Liu SQ, Jing B, Yuan C, Liu XY, Jiao T, Li HC, Wang HY.
    Biosci Rep; 2017 Apr 30; 37(2):. PubMed ID: 28250135
    [Abstract] [Full Text] [Related]

  • 3. The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis.
    Yang B, Xiaping Z.
    Front Surg; 2022 Apr 30; 9():1031108. PubMed ID: 36704514
    [Abstract] [Full Text] [Related]

  • 4. [Correlation between C-reactive protein to albumin ratio and restenosis after femoral popliteal stenting in patients with lower extremity arteriosclerotic obliterans].
    Wang YM, Zhang MQ, Chen ZP, Ji R, Cai J, Qiao T.
    Zhonghua Wai Ke Za Zhi; 2023 Dec 01; 61(12):1058-1064. PubMed ID: 37932141
    [Abstract] [Full Text] [Related]

  • 5. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina.
    Mito T, Miura S, Iwata A, Morii J, Sugihara M, Ike A, Mori K, Kawamura A, Nishikawa H, Zhang B, Saku K.
    Coron Artery Dis; 2011 Nov 01; 22(7):451-7. PubMed ID: 21811155
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic Value of Circulating microRNAs for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease.
    Yuan L, Dong J, Zhu G, Bao J, Lu Q, Zhou J, Jing Z.
    Sci Rep; 2019 Feb 04; 9(1):1402. PubMed ID: 30718561
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease.
    Yu ZH, Wang HT, Tu C.
    Eur J Med Res; 2017 Jan 05; 22(1):2. PubMed ID: 28057086
    [Abstract] [Full Text] [Related]

  • 8. Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: a retrospective comparative cohort study.
    Zhao H, Zhuo T, Hao X, Fan X, Zhao P.
    Ann Palliat Med; 2022 Aug 05; 11(8):2720-2729. PubMed ID: 36064362
    [Abstract] [Full Text] [Related]

  • 9. [Plasma heparin cofactor II activity correlates with the incidence of in-stent restenosis after the intervention of arteriosclerosis obliterans in lower extremity].
    Lu H, Guo P.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Feb 05; 40(2):177-81. PubMed ID: 25769326
    [Abstract] [Full Text] [Related]

  • 10. Impact of plasma aldosterone levels for prediction of in-stent restenosis.
    Amano T, Matsubara T, Izawa H, Torigoe M, Yoshida T, Hamaguchi Y, Ishii H, Miura M, Hayashi Y, Ogawa Y, Murohara T.
    Am J Cardiol; 2006 Mar 15; 97(6):785-8. PubMed ID: 16516576
    [Abstract] [Full Text] [Related]

  • 11. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans.
    Lian W, Nie H, Yuan Y, Wang K, Chen W, Ding L.
    J Invest Surg; 2021 Jul 15; 34(7):765-770. PubMed ID: 31996054
    [Abstract] [Full Text] [Related]

  • 12. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.
    Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM.
    Eur Heart J; 2002 May 15; 23(9):726-33. PubMed ID: 11977999
    [Abstract] [Full Text] [Related]

  • 13. Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO.
    Su X, Yuan X, Li F, Yang G, Du L, Zhao F, Zhao R, Ou M.
    PeerJ; 2023 May 15; 11():e16057. PubMed ID: 37744231
    [Abstract] [Full Text] [Related]

  • 14. Olfactomedin 2: expression in the eye and interaction with other olfactomedin domain-containing proteins.
    Sultana A, Nakaya N, Senatorov VV, Tomarev SI.
    Invest Ophthalmol Vis Sci; 2011 Apr 15; 52(5):2584-92. PubMed ID: 21228389
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S, Güneri S, Akdeniz B, Ozcan MA, Baris N, Badak O, Kirimli O, Yüksel F.
    Am J Cardiol; 2006 Jan 15; 97(2):198-202. PubMed ID: 16442363
    [Abstract] [Full Text] [Related]

  • 16. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM.
    Chin Med J (Engl); 2013 Mar 15; 126(6):1019-25. PubMed ID: 23506572
    [Abstract] [Full Text] [Related]

  • 17. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.
    Szkodzinski J, Hudzik B, Romanowski W, Wilczek K, Danikiewicz A, Gasior M, Polonski L, Zubelewicz-Szkodzinska B.
    J Biol Regul Homeost Agents; 2010 Mar 15; 24(2):149-56. PubMed ID: 20487628
    [Abstract] [Full Text] [Related]

  • 18. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
    Yılmaz S, Sen F, Ünal S, Yayla C, Özeke Ö, Aras D, Topaloglu S, Aydogdu S.
    Scand Cardiovasc J; 2015 Feb 15; 49(1):39-44. PubMed ID: 25414124
    [Abstract] [Full Text] [Related]

  • 19. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
    L'Allier PL, Tardif JC, Grégoire J, Joyal M, Lespérance J, Fortier A, Guertin MC.
    Can J Cardiol; 2005 May 01; 21(6):495-500. PubMed ID: 15917878
    [Abstract] [Full Text] [Related]

  • 20. Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis.
    He M, Gong Y, Shi J, Pan Z, Zou H, Sun D, Tu X, Tan X, Li J, Li W, Liu B, Xue J, Sheng L, Xiu C, Yang N, Xue H, Ding X, Yu C, Li Y.
    PLoS One; 2014 May 01; 9(11):e112043. PubMed ID: 25427155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.